Trial intelligence / Profile preview

Vonorasan vs esomeprazole for post-ESD gastric ulcers

ChiCTR2400086012Phase 4Not yet recruiting

Sponsor
The Affiliated Hospital of Guangdong Medical University
Start
Jun 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of vonoprazan in gastric ulcer (2 arms), sponsored by The Affiliated Hospital of Guangdong Medical University. Primary endpoint: Rate of ulcer reduction at week 8. Planned start Jun 2024; status: not yet recruiting.

02

Drugs

vonoprazan
03

Conditions

gastric ulcer

Beyond the preview

Go deeper on ChiCTR2400086012.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400086012.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call